103 related articles for article (PubMed ID: 3131591)
41. Synthesis of DNA and lecithin in tissue culture and oestrogen receptor activity in rat mammary tumours dependent on and independent of the ovary.
Scott AM; Murphy S; Hawkins RA
J Endocrinol; 1979 May; 81(2):183-98. PubMed ID: 110901
[TBL] [Abstract][Full Text] [Related]
42. Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.
Murphy PR; Butts C; Lazier CB
Endocrinology; 1984 Jul; 115(1):420-6. PubMed ID: 6734522
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
44. Characterization and assay of progesterone-binding components in DMBA-induced rat mammary carcinoma tissue after progesterone administration.
Geier A; Shelef M; Beery R; Lunenfeld B
J Steroid Biochem; 1983 Sep; 19(3):1301-7. PubMed ID: 6413784
[TBL] [Abstract][Full Text] [Related]
45. Distribution of antiestrogen-specific binding sites in normal and neoplastic mammary gland.
Mehta RG; Cerny WL; Moon RC
Oncology; 1984; 41(6):387-92. PubMed ID: 6504492
[TBL] [Abstract][Full Text] [Related]
46. Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.
Görlich M; Winterfeld G; Hauff P; Arnold W; Fichtner I; Staab HJ
J Cancer Res Clin Oncol; 1992; 119(2):97-100. PubMed ID: 1429832
[TBL] [Abstract][Full Text] [Related]
47. Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes.
Pietras RJ; Szego CM
Biochem J; 1980 Dec; 191(3):743-60. PubMed ID: 7283971
[TBL] [Abstract][Full Text] [Related]
48. Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis.
Jordan VC; Prestwich G
Mol Cell Endocrinol; 1977 Sep; 8(3):179-88. PubMed ID: 924012
[TBL] [Abstract][Full Text] [Related]
49. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
[TBL] [Abstract][Full Text] [Related]
50. Quantitative estimates of cytoplasmic and nuclear oestrogen receptors in chick oviduct. Effect of oestrogen on receptor concentration and subcellular distribution.
Sutherland RL; Baulieu EE
Eur J Biochem; 1976 Nov; 70(2):531-41. PubMed ID: 1009940
[TBL] [Abstract][Full Text] [Related]
51. Comparison of glucocorticoid-binding proteins in normal and neoplastic mammary tissues of the rat.
Goral JE; Wittliff JL
Biochemistry; 1975 Jul; 14(13):2944-52. PubMed ID: 238578
[TBL] [Abstract][Full Text] [Related]
52. Effect of hormone manipulation on oxidation, reduction and sulphurylation of dehydroepiandrosterone and oestrone in DMBA-induced rat mammary tumours.
Li K; Chandra DP; Pewnim T; Foo T; Adams JB
Br J Cancer; 1980 Jan; 41(1):123-9. PubMed ID: 6444830
[TBL] [Abstract][Full Text] [Related]
53. (3H)Tamoxifen binding studies in dimethylbenzanthracene-induced mammary carcinomata [proceedings].
Nicholson RI; Daniel CP; Davies P; Griffiths K
J Endocrinol; 1977 Dec; 75(3):26P. PubMed ID: 591830
[No Abstract] [Full Text] [Related]
54. Interaction of unsaturated fatty acids with anti-oestrogen-binding sites.
Hwang PL
Biochem J; 1987 Apr; 243(2):359-64. PubMed ID: 3632626
[TBL] [Abstract][Full Text] [Related]
55. Biological activity of [127I] and [125I] estradiol analogs in vitro and in vivo.
Longcope C; Arunachalam T; Rafkind I; Caspi E
J Steroid Biochem; 1981 Mar; 14(3):261-8. PubMed ID: 6783784
[No Abstract] [Full Text] [Related]
56. Nuclear interactions of zearalanol-oestrogen receptor complexes in rat liver: a comparison with oestradiol-17 beta.
Mastri C; Sloop TC; Lucier GW
J Steroid Biochem; 1986 Feb; 24(2):519-23. PubMed ID: 3702436
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptor binding radiopharmaceuticals: II. Tissue distribution of 17 alpha-methylestradiol in normal and tumor-bearing rats.
Feenstra A; Vaalburg W; Nolten GM; Reiffers S; Talma AG; Wiegman T; van der Molen HD; Woldring MG
J Nucl Med; 1983 Jun; 24(6):522-8. PubMed ID: 6406650
[TBL] [Abstract][Full Text] [Related]
58. The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens.
Jordan VC; Naylor KE
Br J Pharmacol; 1979 Feb; 65(2):167-73. PubMed ID: 760895
[TBL] [Abstract][Full Text] [Related]
59. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Verdeal K; Brown RR; Richardson T; Ryan DS
J Natl Cancer Inst; 1980 Feb; 64(2):285-90. PubMed ID: 6766510
[TBL] [Abstract][Full Text] [Related]
60. Estimation of total oestrogen receptors in DMBA-induced rat mammary tumors by exchange of nuclear bound ligand at low temperature; a comparison with rat uterus.
Blankenstein MA; Peters-Mechielsen MJ; Mulder E; Van der Molen HJ
J Steroid Biochem; 1980 May; 13(5):557-64. PubMed ID: 6771469
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
